NRX Pharmaceuticals

NRXPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$129.700 M

$3.58 +15.86%

Close of 7 Aug 2026

Revenue

$1.23M

#3487 by revenue

Earnings

-$28.6M

Loss-making

Shares outstanding

33,067,630

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#293InflaRxIFRX$133.0M
#294ProMIS NeurosciencesPMN$131.9M
#295NRX PharmaceuticalsNRXP$129.7M
#296Spruce BiosciencesSPRB$129.0M
#297Tiziana Life SciencesTLSA$127.3M

Where these numbers come from

Share counts and financials for NRX Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.